CTSA Working Group Advances Dissemination and Implementation Science
Provides ICTS Investigator Valuable Opportunity for Professional Development The CTSA program provides opportunities for hub members to come together and advance knowledge and progress around various topics. One way this is accomplished is through working groups. Working groups consider and develop solutions around a specific clinical and translational science issue and provide deliverables that fill […]
WashU Investigator Team Utilize ICTS Resources to Prepare for Successful R01 Grant Submission
Planning for your first R01 application can be daunting. Even for seasoned investigators, it takes time and requires sufficient preparation. Early-stage investigators can find needed support by utilizing resources from the ICTS throughout their grant submission process. Recently funded by the National Institute on Aging with the National Institutes of Health (NIH), ICTS members, Sarah […]
KL2 Scholar Utilizes CTSA Resources to Advance MRSA Research
Breakthrough research is rarely accomplished in a vacuum. Years of training, time spent writing and countless hours coordinating resources is an inherent part of any researcher’s work on the path to a successful study. Such is the case for Stephanie Fritz, MD, MSCI, ICTS member and senior author of a new study on how the […]
Investigator and Bioethics Expert James DuBois Weighs In on the Ethical and Practical Barriers to Qualitative Data Sharing
Qualitative data—such as data from interview or focus group studies—has a unique value in understanding health behaviors and traits. It is often used to understand attitudes and preferences, as well as complex and hidden behaviors. Qualitative research has led to deeper understandings of risk factors for HIV, teen pregnancy, and illegal drug use. When participants […]
Suresh Vedantham, MD
Congratulations to Suresh Vedantham, MD (Department of Radiology; Assistant Dean for Clinical Research) who recently received a Top 10 Clinical Research Achievement Award from the Clinical Research Forum on behalf of the ATTRACT Trial Investigators. The ATTRACT trial concluded that clot-busting drugs do not prevent long-term blood clot complications for most patients with deep vein […]